The new nod could boost sales of the French drugmaker's vaccine, a lift it could use after Menactra's top-line haul in 2013 sank to €424 million in a 21.5% slide.
Health Canada gave the nod to Sanofi Pasteur Canada to expand the indication for Menactra to infants 9 months of age.
As H1 came to a close, FierceVaccines decided to take a look at which prophylactic vaccines flew off the shelves--and which companies made the sales.
As H1 came to a close, FierceVaccines decided to take a look at which prophylactic vaccines flew off the shelves--and which companies made the sales. Take a look at the full list >>
Sanofi Pasteur may find itself in the thick of an antitrust case after a judge ruled that a lawsuit alleging that the company illegally monopolizes the market for meningococcal vaccines in the U.S. can move forward.
The FDA has expanded the indication of Sanofi-Aventis' Menactra to include a two-dose schedule for infants and children 9 months through 23 months of age, marking the first time a meningococcal
The CDC's Advisory Committee on Immunization Practices voted 6-5 Wednesday to add a booster dose of the meningitis vaccine at age 16. Reuters notes that health officials want to address waning